Sociodemographic, Lifestyle, and Quality of Life Determinants of Atherogenic Risk: A Cross-Sectional Study in a Large Cohort of Spanish Workers
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Anthropometric and Clinical Measurements
2.3. Atherogenic Risk Assessment
2.4. Lifestyle and Behavioral Variables
2.5. Sociodemographic Variables
2.6. Health-Related Quality of Life
2.7. Statistical Analysis
3. Results
4. Discussion
Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Chen, W.; Li, Z.; Zhao, Y.; Chen, Y.; Huang, R. Global and national burden of atherosclerosis from 1990 to 2019: Trend analysis based on the Global Burden of Disease Study 2019. Chin. Med. J. 2023, 136, 2442–2450. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Nedkoff, L.; Briffa, T.; Zemedikun, D.; Herrington, S.; Wright, F.L. Global Trends in Atherosclerotic Cardiovascular Disease. Clin. Ther. 2023, 45, 1087–1091. [Google Scholar] [CrossRef] [PubMed]
- Ibanez, B.; Fernández-Ortiz, A.; Fernández-Friera, L.; García-Lunar, I.; Andrés, V.; Fuster, V. Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8. J. Am. Coll. Cardiol. 2021, 78, 156–179. [Google Scholar] [CrossRef] [PubMed]
- SSánchez-Cabo, F.; Fuster, V.; Silla-Castro, J.C.; González, G.; Lorenzo-Vivas, E.; Alvarez, R.; Callejas, S.; Benguría, A.; Gil, E.; Núñez, E.; et al. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: A multi-omics study. Eur. Heart J. 2023, 44, 2698–2709. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Medina-Leyte, D.J.; Zepeda-García, O.; Domínguez-Pérez, M.; González-Garrido, A.; Villarreal-Molina, T.; Jacobo-Albavera, L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int. J. Mol. Sci. 2021, 22, 3850. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Fan, J.; Watanabe, T. Atherosclerosis: Known and unknown. Pathol. Int. 2022, 72, 151–160. [Google Scholar] [CrossRef] [PubMed]
- Priya, H.K.; Jha, K.P.; Kumar, N.; Singh, S. Reactive Oxygen Species and Mitochondrial Calcium’s Roles in the Development of Atherosclerosis. Curr. Pharm. Des. 2024, 30, 1812–1821. [Google Scholar] [CrossRef] [PubMed]
- Batty, M.; Bennett, M.R.; Yu, E. The Role of Oxidative Stress in Atherosclerosis. Cells 2022, 11, 3843. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Gonçalves, A.C. Oxidative stress and high-density lipoprotein cholesterol: Cause or consequence? Rev. Port. Cardiol. 2022, 41, 841–842, (In English, Portuguese). [Google Scholar] [CrossRef] [PubMed]
- Wu, J.-H.; Lv, C.-F.; Guo, X.-J.; Zhang, H.; Zhang, J.; Xu, Y.; Wang, J.; Liu, S.-Y. Low Dose of Emodin Inhibits Hypercholesterolemia in a Rat Model of High Cholesterol. Med. Sci. Monit. 2021, 27, e929346. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Robert, J.; Osto, E.; von Eckardstein, A. The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions. Cells 2021, 10, 1041. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- von Eckardstein, A.; Nordestgaard, B.G.; Remaley, A.T.; Catapano, A.L. High-density lipoprotein revisited: Biological functions and clinical relevance. Eur. Heart J. 2023, 44, 1394–1407. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Martínez-Almoyna Rifá, E.; Tomás-Gil, P.; Coll Villalonga, J.L.; Ramírez-Manent, J.I.; Martí-Lliteras, P.; López-González, A.A. Relationship between values of 7 NAFLD scales and different RCV scales in 219,477 Spanish workers. Acad. J. Health Sci. 2023, 38, 52–59. [Google Scholar] [CrossRef]
- Gravan Bru, M.; Tárraga López, P.J.; Tárraga Marcos, M.L. Riesgos cardiovasculares en pacientes crónicos. Acad. J. Health Sci. 2024, 39, 161–179. [Google Scholar] [CrossRef]
- Hoogeveen, R.C.; Ballantyne, C.M. Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation. Clin. Chem. 2021, 67, 143–153. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Agudo, S.G.; Casquero, R.G.; Rojas, D.P.V.; Escribano, H.E.; Martín, J.A.R.; Llinás, M.G. Relevancia de los índices aterogénicos como predictores precoces de riesgo cardiovascular en el contexto laboral de los profesionales sanitarios. Acad. J. Health Sci. 2024, 39, 15–22. [Google Scholar] [CrossRef]
- Araújo, Y.B.; Almeida, A.B.R.; Viana, M.F.M.; Meneguz-Moreno, R.A. Use of Atherogenic Indices as Assessment Methods of Clinical Atherosclerotic Diseases. Arq. Bras. Cardiol. 2023, 120, e20230418, (In Portuguese, English). [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- García, J.J.T. Atherogenic indices: Usefulness as predictors of cardiovascular disease. Clin. Investig. Arterioscler. 2022, 34, 269–270, (In Portuguese, English). [Google Scholar] [CrossRef] [PubMed]
- Prasad, M.; Sara, J.; Widmer, R.J.; Lennon, R.; Lerman, L.O.; Lerman, A. Triglyceride and Triglyceride/HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease. J. Am. Heart Assoc. 2019, 8, e009442. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yang, S.-H.; Du, Y.; Li, X.-L.; Zhang, Y.; Li, S.; Xu, R.-X.; Zhu, C.-G.; Guo, Y.-L.; Wu, N.-Q.; Qing, P.; et al. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease. Am. J. Med. Sci. 2017, 354, 117–124. [Google Scholar] [CrossRef] [PubMed]
- Wang, L.; Cong, H.; Zhang, J.; Hu, Y.; Wei, A.; Zhang, Y.; Yang, H.; Ren, L.; Qi, W.; Li, W. Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins. Front. Cardiovasc. Med. 2021, 8, 718604. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Zhou, S.; Qiu, M.; Wang, K.; Li, J.; Li, Y.; Han, Y. Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI. Sci. Rep. 2024, 14, 31752. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ren, X.; Wang, X. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: A cohort study. Curr. Med. Res. Opin. 2023, 39, 1175–1181. [Google Scholar] [CrossRef] [PubMed]
- Wu, Z.; Li, X.; Wen, Q.; Tao, B.; Qiu, B.; Zhang, Q.; Wang, J. Serum LDL-C/HDL-C ratio and the risk of carotid plaques: A longitudinal study. BMC Cardiovasc. Disord. 2022, 22, 501. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Karimi, M.; Brazier, J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Pharmacoeconomics 2016, 34, 645–649. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.; Xu, J.; Gao, Y.; Zheng, J. The relationship between health behaviors and quality of life: The mediating roles of activities of daily living and psychological distress. Front. Public Health 2024, 12, 1398361. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Nevarez-Flores, A.G.; Chappell, K.J.; Morgan, V.A.; Neil, A.L. Health-Related Quality of Life Scores and Values as Predictors of Mortality: A Scoping Review. J. Gen. Intern. Med. 2023, 38, 3389–3405. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Fawkes, L.S.; Roh, T.; McDonald, T.J.; Horney, J.A.; Chiu, W.A.; Sansom, G.T. Using the 12-item short-form health survey (SF-12) to evaluate self-rated health in an environmental justice community. Arch. Public Health 2024, 82, 186. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Saboya, P.P.; Bodanese, L.C.; Zimmermann, P.R.; Gustavo, A.D.; Assumpção, C.M.; Londero, F. Metabolic syndrome and quality of life: A systematic review. Rev. Lat. Am. Enfermagem. 2016, 24, e2848. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Komalasari, R.; Nurjanah Yoche, M.M. Quality of Life of People with Cardiovascular Disease: A Descriptive Study. Asian Pac. Isl. Nurs. J. 2019, 4, 92–96. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ownby, R.L.; Acevedo, A.; Jacobs, R.J.; Caballero, J.; Waldrop-Valverde, D. Quality of life, health status, and health service utilization related to a new measure of health literacy: FLIGHT/VIDAS. Patient Educ. Couns. 2014, 96, 404–410. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- TTristão-Pereira, C.; Fuster, V.; Lopez-Jimenez, A.; Fernández-Pena, A.; Semerano, A.; Fernandez-Nueda, I.; Garcia-Lunar, I.; Ayuso, C.; Sanchez-Gonzalez, J.; Ibanez, B.; et al. Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain study. Am. Heart J. 2024, 278, 195–207. [Google Scholar] [CrossRef] [PubMed]
- Abrantes, L.C.S.; Morais, N.d.S.d.; Gonçalves, V.S.S.; Ribeiro, S.A.V.; Sediyama, C.M.N.d.O.; Franceschini, S.D.C.C.; Amorim, P.R.d.S.; Priore, S.E. Physical activity and quality of life among college students without comorbidities for cardiometabolic diseases: Systematic review and meta-analysis. Qual. Life Res. 2022, 31, 1933–1962. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Weber, R.M.; Anand, C.; Koeder, C.; Husain, S.; Schoch, N.; Kettler, C.; Buyken, A.; Englert, H. Healthy lifestyle changes can improve quality of life: The Healthy Lifestyle Community Program (cohort 2; HLCP-2). J. Public Health 2025. [Google Scholar] [CrossRef]
- Scott, D.J.; Arthurs, Z.M.; Stannard, A.; Monroe, H.M.; Clouse, W.D.; Rasmussen, T.E. Patient-based outcomes and quality of life after salvageable wartime extremity vascular injury. J. Vasc. Surg. 2014, 59, 173–179.e1. [Google Scholar] [CrossRef] [PubMed]
- Pascual-Morena, C.; Cavero-Redondo, I.; Martínez-García, I.; Rodríguez-Gutiérrez, E.; Lucerón-Lucas-Torres, M.; Moreno-Herráiz, N.; Díaz-Goñi, V.; Saz-Lara, A. Exploring the Influence of Insulin Resistance on Arterial Stiffness in Healthy Adults: From the Metabolic and Cardiovascular Health Insights of the EVasCu Study. Nutrients 2024, 16, 791. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Vicente-Herrero, M.T.; Ramírez-Iñiguez de la Torre, M.V.; López González, A.A. Estimación del nivel de riesgo cardiometabolico relacionado con obesidad en trabajadores sanitarios españoles. Acad. J. Health Sci. 2023, 38, 89–95. [Google Scholar] [CrossRef]
- Manzanero, R.Z.; López-González, A.A.; Tomás-Gil, P.; Paublini, H.; Martínez-Jover, A.; Ramírez-Manent, J.I. Determination of cardiometabolic risk scales in 7.962 hotel receptionists. Acad. J. Health Sci. 2024, 39, 113–122. [Google Scholar] [CrossRef]
- Chen, Q.-J.; Lai, H.-M.; Chen, B.-D.; Li, X.-M.; Zhai, H.; He, C.-H.; Pan, S.; Luo, J.-Y.; Gao, J.; Liu, F.; et al. Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang, China. Int. J. Environ. Res. Public Health 2016, 13, 235. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Assempoor, R.; Daneshvar, M.S.; Taghvaei, A.; Abroy, A.S.; Azimi, A.; Nelson, J.R.; Hosseini, K. Atherogenic index of plasma and coronary artery disease: A systematic review and meta-analysis of observational studies. Cardiovasc. Diabetol. 2025, 24, 35. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ramírez-Manent, J.I.; Tomás-Gil, P.; Coll-Villalonga, J.L.; Marti-Lliteras, P.; López-González, A.A.; Paublini, H. Relationship between atherogenic dyslipidemia and lipid triad with scales that assess non alcoholic liver disease in 418,343 spanish workers. Acad. J. Health Sci. 2023, 38, 66–73. [Google Scholar] [CrossRef]
- Malick, W.A.; Al Dhaybi, O.; Bhatt, D.L. Atherogenic dyslipidemia: A marker of cardiovascular risk in treated hypertension. Prog. Cardiovasc. Dis. 2025, 23, S0033–S0620. [Google Scholar] [CrossRef] [PubMed]
- Bekar, C.; Goktas, Z. Validation of the 14-item mediterranean diet adherence screener. Clin. Nutr. ESPEN 2023, 53, 238–243. [Google Scholar] [CrossRef] [PubMed]
- Mestre Font, M.; Busquets-Cortés, C.; Ramírez-Manent, J.I.; Vallejos, D.; Sastre Alzamora, T.; López-González, A.A. Influence of sociodemographic variables and healthy habits on the values of cardiometabolic risk scales in 386924 spanish workers. Acad. J. Health Sci. 2024, 39, 112–121. [Google Scholar] [CrossRef]
- Meh, K.; Jurak, G.; Sorić, M.; Rocha, P.; Sember, V. Validity and Reliability of IPAQ-SF and GPAQ for Assessing Sedentary Behaviour in Adults in the European Union: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2021, 18, 4602. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Aguiló Juanola, M.C.; López-González, A.A.; Tomás-Gil, P.; Paublini, H.; Tárraga-López, P.J.; Ramírez-Manent, J.I. Influence of tobacco consumption on the values of different overweight and obesity scales in 418,343 spanish people. Acad. J. Health Sci. 2023, 38, 111–117. [Google Scholar] [CrossRef]
- Ware JJr Kosinski, M.; Keller, S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34, 220–233. [Google Scholar] [CrossRef] [PubMed]
- Millán, J.; Pintó, X.; Muñoz, A.; Zúñiga, M.; Rubiés-Prat, J.; Pallardo, L.F.; Masana, L.; Mangas, A.; Hernández-Mijares, A.; González-Santos, P.; et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc. Health Risk Manag. 2009, 5, 757–765. [Google Scholar] [PubMed] [PubMed Central]
- Sastre-Alzamora, T.; Tárraga López, P.J.; López-González, Á.A.; Vallejos, D.; Paublini, H.; Ramírez Manent, J.I. Usefulness of Atherogenic Indices for Predicting High Values of Avoidable Lost Life Years Heart Age in 139,634 Spanish Workers. Diagnostics 2024, 14, 2388. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Castelli, W.P.; Garrison, R.J.; Wilson, P.W.; Abbott, R.D.; Kalousdian, S.; Kannel, W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986, 256, 2835–2838. [Google Scholar] [CrossRef] [PubMed]
- Jung, E.; Kong, S.Y.; Ro, Y.S.; Ryu, H.H.; Shin, S.D. Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. Int. J. Environ. Res. Public Health 2022, 19, 8272. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yin, B.; Wu, Z.; Xia, Y.; Xiao, S.; Chen, L.; Li, Y. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: A cross-sectional study. Cardiovasc. Diabetol. 2023, 22, 157. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hu, Y.; Liang, Y.; Li, J.; Li, X.; Yu, M.; Cui, W. Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: A nationwide prospective cohort study. Cardiovasc. Diabetol. 2025, 24, 40. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Won, K.-B.; Heo, R.; Park, H.-B.; Lee, B.K.; Lin, F.Y.; Hadamitzky, M.; Kim, Y.-J.; Sung, J.M.; Conte, E.; Andreini, D.; et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis 2021, 324, 46–51. [Google Scholar] [CrossRef] [PubMed]
- Muscogiuri, G.; Verde, L.; Sulu, C.; Katsiki, N.; Hassapidou, M.; Frias-Toral, E.; Cucalón, G.; Pazderska, A.; Yumuk, V.D.; Colao, A.; et al. Mediterranean Diet and Obesity-related Disorders: What is the Evidence? Curr. Obes. Rep. 2022, 11, 287–304. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Panagiotakis, S.H.; Simos, P.; Basta, M.; Zaganas, I.; Perysinaki, G.S.; Akoumianakis, I.; Tziraki, C.; Lionis, C.; Vgontzas, A.; Boumpas, D. Interactions of Mediterranean Diet, Obesity, Polypharmacy, Depression and Systemic Inflammation with Frailty Status. Maedica 2022, 17, 20–27. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Fatima, K.; Rashid, A.M.; Memon, U.A.A.; Fatima, S.S.; Javaid, S.S.; Shahid, O.; Zehri, F.; Obaid, M.A.; Ahmad, M.; Almas, T.; et al. Mediterranean Diet and its Effect on Endothelial Function: A Meta-analysis and Systematic Review. Ir. J. Med. Sci. 2023, 192, 105–113. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Madan, K.; Sawhney, J.P.S. Exercise and lipids. Indian Heart J. 2024, 76 (Suppl. 1), S73–S74. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Alaminos-Torres, A.; Martínez-Álvarez, J.R.; López-Ejeda, N.; Marrodán-Serrano, M.D. Atherogenic Risk, Anthropometry, Diet and Physical Activity in a Sample of Spanish Commercial Airline Pilots. Int. J. Environ. Res. Public Health 2022, 19, 4128. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Korshøj, M.; Allesøe, K.; Mortensen, O.S.; Siersma, V.; Kauhanen, J.; Krause, N. Occupational physical activity predicts baseline and 8-year progression of carotid atherosclerosis among women. Scand. J. Med. Sci. Sports 2023, 33, 1792–1806. [Google Scholar] [CrossRef] [PubMed]
- Lear, S.A.; Hu, W.; Rangarajan, S.; Gasevic, D.; Leong, D.; Iqbal, R.; Casanova, A.; Swaminathan, S.; Anjana, R.M.; Kumar, R.; et al. The effect of physical activity on mortality and cardiovascular disease in 130,000 people from 17 high-income, middle-income, and low-income countries: The PURE study. Lancet 2017, 390, 2643–2654, Erratum in Lancet 2017, 390, 2626. https://doi.org/10.1016/S0140-6736(17)32596-5. [Google Scholar] [CrossRef] [PubMed]
- Alonso, J.; Ferrer, M.; Gandek, B.; Ware, J.E., Jr.; Aaronson, N.K.; Mosconi, P.; Rasmussen, N.K.; Bullinger, M.; Fukuhara, S.; Kaasa, S.; et al. Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Qual. Life Res. 2004, 13, 283–298. [Google Scholar] [CrossRef] [PubMed]
- Levine, G.N.; Cohen, B.E.; Commodore-Mensah, Y.; Fleury, J.; Huffman, J.C.; Khalid, U.; Labarthe, D.R.; Lavretsky, H.; Michos, E.D.; Spatz, E.S.; et al. Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association. Circulation 2021, 143, e763–e783. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Ozodiegwu, I.D.; Nickel, J.C.; Wang, K.; Iwasaki, L.R. Self-reported health and behavioral factors are associated with metabolic syndrome in Americans aged 40 and over. Prev. Med. Rep. 2017, 7, 193–197. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Noh, J.W.; Chang, Y.; Park, M.; Kwon, Y.D.; Ryu, S. Self-rated health and the risk of incident type 2 diabetes mellitus: A cohort study. Sci. Rep. 2019, 9, 3697. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Bao, X.; Borné, Y.; Yin, S.; Niu, K.; Orho-Melander, M.; Nilsson, J.; Melander, O.; Engström, G. The associations of self-rated health with cardiovascular risk proteins: A proteomics approach. Clin. Proteomics. 2019, 16, 40. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Park, S.; Lee, H.J.; Jeon, B.J.; Yoo, E.Y.; Kim, J.B.; Park, J.H. Effects of occupational balance on subjective health, quality of life, and health-related variables in community-dwelling older adults: A structural equation modeling approach. PLoS ONE 2021, 16, e0246887. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Martinelli, L.M.; Mizutani, B.M.; Mutti, A.; D'elia, M.P.; Coltro, R.S.; Matsubara, B.B. Quality of life and its association with cardiovascular risk factors in a community health care program population. Clinics 2008, 63, 783–788. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Snarska, K.; Chorąży, M.; Szczepański, M.; Wojewódzka-Żelezniakowicz, M.; Ładny, J.R. Quality of Life of Patients with Arterial Hypertension. Medicina 2020, 56, 459. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rozjabek, H.; Fastenau, J.; LaPrade, A.; Sternbach, N. Adult Obesity and Health-Related Quality of Life, Patient Activation, Work Productivity, and Weight Loss Behaviors in the United States. Diabetes Metab. Syndr. Obes. 2020, 13, 2049–2055. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Jordakieva, G.; Markovic, L.; Rinner, W.; Santonja, I.; Lee, S.; Pilger, A.; Perkman, T.; Grabovac, I.; Schernhammer, E.; Crevenna, R.; et al. Workability, quality of life and cardiovascular risk markers in aging nightshift workers: A pilot study. Wien. Klin. Wochenschr. 2022, 134, 276–285. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Variable | Total (n = 100,014) | Men (n = 60,133) | Women (n = 39,881) | p-Value |
---|---|---|---|---|
Age, years (mean ± SD) | 44.8 ± 9.6 | 45.2 ± 9.5 | 44.1 ± 9.7 | <0.001 |
BMI, kg/m2 (mean ± SD) | 26.7 ± 4.3 | 27.3 ± 4.1 | 25.9 ± 4.4 | <0.001 |
Waist circumference, cm | 89.6 ± 12.7 | 94.1 ± 11.4 | 82.5 ± 11.1 | <0.001 |
Systolic BP, mmHg | 123.4 ± 14.9 | 126.1 ± 14.7 | 119.1 ± 14.2 | <0.001 |
Diastolic BP, mmHg | 77.6 ± 9.8 | 79.2 ± 9.6 | 75.1 ± 9.4 | <0.001 |
Glucose, mg/dL | 96.3 ± 16.5 | 98.2 ± 16.7 | 93.7 ± 16.0 | <0.001 |
Total cholesterol, mg/dL | 199.1 ± 36.2 | 198.6 ± 35.9 | 199.8 ± 36.6 | 0.02 |
HDL-c, mg/dL | 55.8 ± 14.7 | 50.1 ± 12.5 | 64.2 ± 14.2 | <0.001 |
Triglycerides, mg/dL | 123.7 ± 85.4 | 136.8 ± 91.3 | 105.4 ± 72.1 | <0.001 |
Current smokers, % | 25.8 | 28.5 | 21.4 | <0.001 |
Physical activity (≥150 min/week) | 42.6 | 39.3 | 47.5 | <0.001 |
Mediterranean diet adherence, % | 36.2 | 33.1 | 40.8 | <0.001 |
TC/HDL-c | LDL-c/HDL-c | TG/HDL-c | |||||
---|---|---|---|---|---|---|---|
Men | n | Mean (SD) | p-Value | Mean (SD) | p-Value | Mean (SD) | p-Value |
18–29 years | 10,774 | 3.2 (0.8) | <0.001 | 1.8 (0.7) | <0.001 | 1.8 (1.4) | <0.001 |
30–39 years | 19,795 | 3.7 (1.0) | 2.3 (0.8) | 2.4 (2.1) | |||
40–49 years | 17,850 | 4.2 (1.2) | 2.7 (1.0) | 2.9 (2.5) | |||
50–59 years | 9915 | 4.5 (1.2) | 2.9 (1.0) | 3.0 (1.9) | |||
60–69 years | 1799 | 4.6 (1.2) | 3.0 (1.0) | 3.2 (2.5) | |||
Social class I | 3208 | 3.9 (1.1) | <0.001 | 2.4 (0.9) | <0.001 | 2.4 (1.9) | <0.001 |
Social class II | 10,602 | 4.0 (1.1) | 2.5 (0.9) | 2.5 (2.2) | |||
Social class III | 46,323 | 4.0 (1.2) | 2.5 (1.0) | 2.6 (2.3) | |||
Smokers | 22,265 | 3.9 (1.1) | <0.001 | 2.4 (0.9) | <0.001 | 2.4 (1.8) | <0.001 |
Non-smokers | 37,868 | 4.0 (1.3) | 2.5 (1.1) | 2.9 (2.8) | |||
Adherence to the Mediterranean diet | 24,790 | 3.3 0.7) | <0.001 | 2.0 (0.6) | <0.001 | 1.6 (0.7) | <0.001 |
Non-adherence to the Mediterranean diet | 35,343 | 4.4 (1.2) | 2.7 (1.1) | 3.3 (2.6) | |||
Perform physical activity | 27,551 | 3.4 (0.7) | <0.001 | 2.1 (0.7) | <0.001 | 1.6 (0.6) | <0.001 |
Physical inactivity | 32,582 | 4.4 (1.3) | 2.8 (1.1) | 3.4 (2.7) | |||
SF-12 normal | 41,843 | 3.7 (0.9) | <0.001 | 2.3 (0.8) | <0.001 | 1.8 (0.9) | <0.001 |
SF-12 low | 18,290 | 4.6 (1.4) | 2.8 (1.2) | 4.2 (3.3) | |||
Women | n | Mean (SD) | p-Value | Mean (SD) | p-Value | Mean (SD) | p-Value |
18–29 years | 7747 | 3.2 (0.8) | <0.001 | 1.9 (0.7) | <0.001 | 1.4 (0.8) | <0.001 |
30–39 years | 13,365 | 3.5 (1.0) | 2.2 (0.9) | 1.5 (0.9) | |||
40–49 years | 11,626 | 3.9 (1.0) | 2.5 (0.9) | 1.8 (1.1) | |||
50–59 years | 6121 | 4.4 (1.1) | 3.0 (1.0) | 2.1 (1.3) | |||
60–69 years | 1022 | 4.5 (1.0) | 3.1 (0.9) | 2.2 (1.0) | |||
Social class I | 2793 | 3.6 (1.0) | <0.001 | 2.2 (0.9) | <0.001 | 1.5 (0.8) | <0.001 |
Social class II | 13,255 | 3.7 (1.0) | 2.3 (0.9) | 1.6 (1.0) | |||
Social class III | 23,833 | 3.8 (1.1) | 2.4 (1.0) | 1.7 (1.0) | |||
Smokers | 13,040 | 3.7 (1.1) | <0.001 | 2.4 (1.0) | <0.001 | 1.8 (1.1) | <0.001 |
Non-Smokers | 26,841 | 3–6 (1.0) | 2.3 (0.9) | 1.7 (1.0) | |||
Adherence to the Mediterranean diet | 20,344 | 3.3 (0.7) | <0.001 | 2.0 (0.7) | <0.001 | 1.3 (0.5) | <0.001 |
Non-adherence to the Mediterranean diet | 19,537 | 4.2 (1.1) | 2.8 (1.1) | 2.1 (1.2) | |||
Perform physical activity | 20,669 | 3.2 (0.7) | <0.001 | 2.0 (0.6) | <0.001 | 1.3 (0.4) | <0.001 |
Physical inactivity | 19,212 | 4.2 (1.1) | 2.8 (1.1) | 2.2 (1.2) | |||
SF-12 normal | 32,173 | 3.5 (0.9) | <0.001 | 2.2 (0.9) | <0.001 | 1.5 (0.6) | <0.001 |
SF-12 low | 7708 | 4.6 (1.1) | 3.1 (1.1) | 2.7 (1.6) |
TC/HDL-c Moderate-High | LDL-c/HDL-c High | TG/HDL-c High | AD | ||||||
---|---|---|---|---|---|---|---|---|---|
Men | n | % | p-Value | % | p-Value | % | p-Value | % | p-Value |
18–29 years | 10,774 | 2.6 | <0.001 | 5.3 | <0.001 | 9.9 | <0.001 | 1.7 | <0.001 |
30–39 years | 19,795 | 8.7 | 15.9 | 19.8 | 4.0 | ||||
40–49 years | 17,850 | 18.6 | 30.6 | 30.4 | 6.1 | ||||
50–59 years | 9915 | 29.0 | 43.2 | 34.7 | 8.1 | ||||
60–69 years | 1799 | 29.2 | 47.0 | 36.3 | 8.4 | ||||
Social class I | 3208 | 13.6 | <0.001 | 22.8 | <0.001 | 20.8 | <0.001 | 3.7 | <0.001 |
Social class II | 10,602 | 14.5 | 23.9 | 24.3 | 4.5 | ||||
Social class III | 46,323 | 14.8 | 25.7 | 24.6 | 4.9 | ||||
Smokers | 22,265 | 15.9 | <0.001 | 24.2 | <0.001 | 27.9 | <0.001 | 9.4 | <0.001 |
Non-smokers | 37,868 | 13.7 | 23.5 | 22.2 | 2.1 | ||||
Adherence to MD | 24,790 | 8.3 | <0.001 | 13.9 | <0.001 | 14.5 | <0.001 | 3.7 | <0.001 |
Non-adherence to MD | 35,343 | 21.9 | 31.7 | 34.0 | 8.5 | ||||
Perform PhA | 27,551 | 7.0 | <0.001 | 10.2 | <0.001 | 12.8 | <0.001 | 3.0 | <0.001 |
Physical inactivity | 32,582 | 23.8 | 37.9 | 38.0 | 9.7 | ||||
SF-12 normal | 41,843 | 7.6 | <0.001 | 18.6 | <0.001 | 8.7 | <0.001 | 4.2 | <0.001 |
SF-12 low | 18,290 | 30.2 | 35.7 | 60.3 | 9.9 | ||||
Women | n | % | p-Value | % | p-Value | % | p-Value | % | p-Value |
18–29 years | 7747 | 6.2 | <0.001 | 7.3 | <0.001 | 4.8 | <0.001 | 0.8 | <0.001 |
30–39 years | 13,365 | 13.6 | 15.5 | 5.7 | 1.4 | ||||
40–49 years | 11,626 | 24.0 | 26.3 | 8.9 | 2.6 | ||||
50–59 years | 6121 | 43.5 | 46.4 | 15.8 | 6.0 | ||||
60–69 years | 1022 | 46.8 | 50.2 | 17.8 | 6.1 | ||||
Social class I | 2793 | 16.5 | <0.001 | 19.5 | <0.001 | 5.1 | <0.001 | 1.9 | <0.001 |
Social class II | 13,255 | 18.8 | 20.9 | 7.7 | 2.2 | ||||
Social class III | 23,833 | 22.1 | 24.1 | 9.0 | 2.7 | ||||
Smokers | 13,040 | 21.6 | <0.001 | 23.9 | <0.001 | 8.9 | <0.001 | 2.5 | <0.001 |
Non-Smokers | 26,841 | 18.6 | 20.3 | 8.0 | 2.4 | ||||
Adherence to MD | 20,344 | 14.9 | <0.001 | 14.8 | <0.001 | 5.9 | <0.001 | 1.2 | <0.001 |
Non-adherence to MD | 19,537 | 27.9 | 30.2 | 10.9 | 4.2 | ||||
Perform PhA | 20,669 | 10.1 | <0.001 | 12.5 | <0.001 | 5.0 | <0.001 | 0.9 | <0.001 |
Physical inactivity | 19,212 | 30.9 | 33.6 | 12.0 | 4.8 | ||||
SF-12 normal | 32,173 | 13.2 | <0.001 | 16.0 | <0.001 | 6.9 | <0.001 | 1.4 | <0.001 |
SF-12 low | 7708 | 51.5 | 50.5 | 19.9 | 5.6 |
TC/HDL-c Moderate-High | LDL-c/HDL-c High | TG/HDL-c High | AD | |||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Women | 1 | 1 | 1 | 1 | ||||
Men | 0.42 (0.40–0.44) | <0.001 | 0.88 (0.85–0.91) | <0.001 | 3.67 (3.49–3.86) | <0.001 | 1.85 (1.69–2.02) | <0.001 |
18–29 years | 1 | 1 | 1 | 1 | ||||
30–39 years | 1.21 (1.17–1.26) | <0.001 | 1.20 (1.16–1.25) | <0.001 | 1.19 (1.16–1.23) | <0.001 | 1.18 (1.14–1.23) | <0.001 |
40–49 years | 1.60 (1.46–1.75) | <0.001 | 1.89 (1.74–2.05) | <0.001 | 1.42 (1.30–1.55) | <0.001 | 1.38 (1.30–1.47) | <0.001 |
50–59 years | 2.69 (2.45–2.94) | <0.001 | 3.39 (3.11–3.68) | <0.001 | 1.95 (1.70–2.21) | <0.001 | 1.91 (1.70–2.12) | <0.001 |
60–69 years | 5.83 (5.19–6.48) | <0.001 | 7.84 (7.09–8.60) | <0.001 | 2.33 (2.01–2.66) | <0.001 | 2.28 (2.00–2.27) | <0.001 |
Social class I | 1 | 1 | 1 | 1 | ||||
Social class II | 1.15 (1.12–1.19) | <0.001 | 1.19 (1.14–1.25) | <0.001 | 1.20 (1.16–1.25) | <0.001 | 1.18 (1.14–1.22) | <0.001 |
Social class III | 1.35 (1.28–1.43) | <0.001 | 1.39 (1.26–1.52) | <0.001 | 1.48 (1.36–1.60) | <0.001 | 1.49 (1.39–1.59) | <0.001 |
Non-smokers | 1 | 1 | 1 | 1 | ||||
Smokers | 1.22 (1.17–1.27) | <0.001 | 1.12 (1.08–1.16) | <0.001 | 1.57 (1.50–1.64) | <0.001 | 3.72 (3.46–3.99) | <0.001 |
Adherence to the Mediterranean diet | 1 | 1 | 1 | 1 | ||||
Non-adherence to the Mediterranean diet | 1.64 (1.49–1.80) | <0.001 | 2.14 (2.00–2.28) | <0.001 | 4.98 (4.59–5.39) | <0.001 | 4.50 (4.02–4.99) | <0.001 |
Perform physical activity | 1 | 1 | 1 | 1 | ||||
Physical inactivity | 8.54 (7.73–9.35) | <0.001 | 3.11 (2.90–3.33) | <0.001 | 7.62 (7.30–7.93) | <0.001 | 8.61 (7.70–9.61) | <0.001 |
SF-12 good | 1 | 1 | 1 | 1 | ||||
SF-12 poor | 2.24 (2.15–2.33) | <0.001 | 1.59 (1.43–1.76) | <0.001 | 4.28 (3.97–4.58) | <0.001 | 3.66 (3.25–4.07) | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marzoa Jansana, M.D.; Tárraga López, P.J.; Guarro Miquel, J.J.; López-González, Á.A.; Riutord Sbert, P.; Busquets-Cortés, C.; Ramírez-Manent, J.I. Sociodemographic, Lifestyle, and Quality of Life Determinants of Atherogenic Risk: A Cross-Sectional Study in a Large Cohort of Spanish Workers. J. Clin. Med. 2025, 14, 6876. https://doi.org/10.3390/jcm14196876
Marzoa Jansana MD, Tárraga López PJ, Guarro Miquel JJ, López-González ÁA, Riutord Sbert P, Busquets-Cortés C, Ramírez-Manent JI. Sociodemographic, Lifestyle, and Quality of Life Determinants of Atherogenic Risk: A Cross-Sectional Study in a Large Cohort of Spanish Workers. Journal of Clinical Medicine. 2025; 14(19):6876. https://doi.org/10.3390/jcm14196876
Chicago/Turabian StyleMarzoa Jansana, María Dolores, Pedro Juan Tárraga López, Juan José Guarro Miquel, Ángel Arturo López-González, Pere Riutord Sbert, Carla Busquets-Cortés, and José Ignacio Ramírez-Manent. 2025. "Sociodemographic, Lifestyle, and Quality of Life Determinants of Atherogenic Risk: A Cross-Sectional Study in a Large Cohort of Spanish Workers" Journal of Clinical Medicine 14, no. 19: 6876. https://doi.org/10.3390/jcm14196876
APA StyleMarzoa Jansana, M. D., Tárraga López, P. J., Guarro Miquel, J. J., López-González, Á. A., Riutord Sbert, P., Busquets-Cortés, C., & Ramírez-Manent, J. I. (2025). Sociodemographic, Lifestyle, and Quality of Life Determinants of Atherogenic Risk: A Cross-Sectional Study in a Large Cohort of Spanish Workers. Journal of Clinical Medicine, 14(19), 6876. https://doi.org/10.3390/jcm14196876